Microvascular rarefaction

References

• Folkman J. Tumor angiogenesis. Adv Cancer Res 1985; 43:175 - 203
   PubMed Web of Science ®Google Scholar
• Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000; 6:389 - 395
   PubMed Web of Science ®Google Scholar
• Dvorak H. How tumors make bad blood vessels and stroma. Am J Pathol 2003; 162:1747 - 1757
   PubMed Web of Science ®Google Scholar
• Yancopoulos G, Davis S, Gale N, Rudge J, Wiegand S, Holash J. Vascular-specific growth factors and blood vessel formation. Nat 2000; 407:242 - 248
   Web of Science ®Google Scholar
• Carmeliet P, Jain R. Angiogenesis in cancer and other diseases. Nat 2000; 407:249 - 257
   Web of Science ®Google Scholar
• Augustin H, Koh G, Thurston G, Alitalo K. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol 2009; 10:165 - 177
   PubMed Web of Science ®Google Scholar
• Benest A, Augustin H. Tension in the vasculature. Nat Med 2009; 15:608 - 610
   PubMed Web of Science ®Google Scholar
• Folkow B. The Forth Volhard lecture: cardiovascular structural adaptation: its role in the initiation and maintenance of primary hypertension. Clin Sci Mol Med 1978; 4:3 - 22
   Google Scholar
• Prewitt R, Chen I, Dowell R. Development of micro-vascular rarefaction in the spontaneously hypertensive rat. Am J Physiol 1982; 243:243 - 251
   PubMed Web of Science ®Google Scholar
• Prewitt R, Cardoso S, Wood W. Prevention of arteriolar rarefaction in the spontaneously hypertensive rat by exposure to simulated high altitude. J Hypertens 1986; 4:735 - 740
   PubMed Web of Science ®Google Scholar
• Hashimoto H, Prewitt R, Efaw C. Alterations in the microvasculature of one-kidney, one-clip hypertensive rats. Am J Physiol 1987; 253:933 - 940
   PubMed Web of Science ®Google Scholar
• Boegenhold M, Johnson M, Overbeck H. Pressure-independent arteriolar rarefaction in hypertension. Am J Physiol 1991; 261:83 - 87
   Google Scholar
• Hansen-Smith F, Morris L, Green A, Lombard J. Rapid microvessel rarefaction with elevated salt intake and reduced renal mass. Circ Res 1996; 79:324 - 330
   PubMed Web of Science ®Google Scholar
• Rieder M, Roman R, Greene A. Hypertension 1997; 30:120 - 127
   PubMed Web of Science ®Google Scholar
• Papanek P, Rieder M, Lombard J, Greene A. Genderspecific protection from microvessel rarefaction in female hypertensive rats. Am J Hypertens 1998; 11:998 - 1005
   PubMed Web of Science ®Google Scholar
• Gobe G, Browning J, Howard T, Hogg N, Winterford C, Cross R. Apoptosis occurs in endothelial cells during hypertension-induced microvascular rarefaction. J Struct Biol 1997; 118:63 - 72
   PubMed Web of Science ®Google Scholar
• Nusz D, White D, Dai Q, Pippen A, Thompson M, Walton G, et al. Vasular rarefaction in peripheral skeletal muscle after experimental heart failure. Am J Physiol 2003; 285:1554 - 1562
   Google Scholar
• Sladek T, Gerova M, Znojil V, Devat L. Morphometric characteristics of cardiac hypertrophy induced by long-term inhibition of NO synthase. Physiol Res 1996; 45:335 - 338
   PubMed Web of Science ®Google Scholar
• Kubis N, Richer C, Domergue V, Giudicelli J, Levy B. Role of microvascular rarefaction in the increased arterial pressure in mice lacking the endothelial nitric oxide synthase gene. J Hypertens 2002; 20:1581 - 1587
   PubMed Web of Science ®Google Scholar
• Okruhlicova L, Tribulova N, Weismann P, Sotnikova R. Ultrastructure and histochemistry of rat myocardial capillary endothelial cells in response to diabetes and hypertension. Cell Res 2005; 15:532 - 538
   PubMed Web of Science ®Google Scholar
• Tornig J, Amann K, Ritz E, Nichols C, Zeier M, Mall G. Arteriolar thickening, capillary rarefaction and interstitial fibrosis in the heart of rats with renal failure: the effects of ramipril, nifedipine and moxonidine. J Am Soc Nephrol 1996; 7:667 - 675
   PubMed Web of Science ®Google Scholar
• Sabri A, Samuel J, Marotte F, Poitevin P, Pappaport L, Levy B. Microvasculature in angiotensin II-dependent cardiac hypertrophy in the rat. Hypertension 1998; 32:371 - 375
   PubMed Web of Science ®Google Scholar
• Sokolova I, Manukhina E, Blinkov S, Koshelev V, Pinelis V, Rodionov I. Rarefaction of arterioles and capillary network in the brain of rats with different forms of hypertension. Microvasc Res 1985; 30:1 - 9
   PubMed Web of Science ®Google Scholar
• Sonntag W, Lynch C, Cooney P, Hutchins P. Decreases in cerebral microvasculature with age are associated with the decline in growth hormone and insulin-like growth factor-1. Endocrinol 1997; 138:3515 - 3520
   PubMed Web of Science ®Google Scholar
• Harper R, Moore M, Marr M, Watts L, Hutchins P. Arteriolar rarefaction in the conjunctiva of human essential hypertension. Microvasc Res 1978; 16:369 - 372
   PubMed Web of Science ®Google Scholar
• Funk R, Rohen J. Comparative morphological studies on blood vessels in eyes of normotensive and spontaneously hypertensive rats. Exp Eye Res 1985; 40:191 - 203
   PubMed Web of Science ®Google Scholar
• Keshet E. Preventing pathological regression of blood vessels. J Clin Invest 2003; 112:27 - 29
   PubMed Web of Science ®Google Scholar
• Montagna W, Carlisle K. Structural changes in aging human skin. J Invest Dermatol 1979; 73:47 - 53
   PubMed Web of Science ®Google Scholar
• Hasan K, Manyonda I, Ng F, Singer D, Antonios T. Skin capillary density changes in normal pregnancy and preeclampsia. J Hypertens 2002; 20:2439 - 2443
   PubMed Web of Science ®Google Scholar
• Houben A, Beljaars J, Hofstra L, Kroon A, De Leeuw P. Microvascular abnormalities in chronic heart failure: a cross-sectional study. Microcirculation 2003; 10:471 - 478
   PubMed Web of Science ®Google Scholar
• Serne E, Gans R, ter Maaten J, Tangelder G, Donker A, Stehouwer C. Impaired skin capillary recruitment in essential hypertension is caused by both functional and structural capillary rarefaction. Hypertension 2001; 38:238 - 242
   PubMed Web of Science ®Google Scholar
• Stewart J, Kohen A, Brouder D, Rahim F, Adler S, Garrick R, Goligorsky MS. Non-invasive interrogation of microvasculature for sigfns of endothelial dysfunction in patients with chronic renal failure. Am J Physiol Heart 2004; 287:2687 - 2696
   PubMed Web of Science ®Google Scholar
• Bohle A, Mackensen-Haen S, von Gise H. Significance of tubulointerstitial changes in the renal cortex for the excretory function and concentration ability of the kidney. Am J Nephrol 1987; 7:421 - 433
   PubMed Web of Science ®Google Scholar
• Lee L, Meyer T, Pollock A, Lovett D. Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney. J Clin Invest 1995; 96:953 - 964
   PubMed Web of Science ®Google Scholar
• Kang D, Joly A, Mazali M, Johnson R. Impaired angiogenesis in the remnant kidney model. J Am Soc Nephrol 2001; 12:1448 - 1457
   PubMed Web of Science ®Google Scholar
• Kang D, Nakagawa T, Feng L, Johnson R. Nitric oxide modulates vascular disease in the remnant kidney model. Am J Pathol 2002; 161:239 - 248
   PubMed Web of Science ®Google Scholar
• Kang D, Kanellis J, Hugo C, Johnson R. Role of microvascular endothelium in progressive renal disease. J Am Soc Nephrol 2002; 13:806 - 816
   PubMed Web of Science ®Google Scholar
• Ohashi R, Kitamura H, Yamanaka N, Johnson R. Peritubular capillary injury during progression of experimental glomerulonephritis in rats. J Am Soc Nephrol 2000; 11:47 - 56
   PubMed Web of Science ®Google Scholar
• Ohashi R, Shimizu A, Masuda Y, Johnson R. Peritubular capillary regression during progression of experimental obstructive nephropathy. J Am Soc Nephrol 2002; 13:1795 - 1805
   PubMed Web of Science ®Google Scholar
• Gealikman O, Brodsky SV, Zhang F, Chander P, Friedli C, Nasjletti A, Goligorsky MS. Angiogenic incompetence and microvasculopathy in the Zucker diabetic fat rat are ameliorated with Ebselen treatment: endothelial dysfunction as a modifier of angiogenic response. Kidney Int 2004; 66:2337 - 2347
   PubMed Web of Science ®Google Scholar
• Namikoshi T, Satoh M, Horike H, Fujimoto S, Arakawa S, Sasaki T, Kashihara N. Implications of peritubular capillary loss and altered expression of vascular endothelial growth factor in IgA nephropathy. Nephron 2006; 102:9 - 16
   Google Scholar
• Vollmar B, Siegmund S, Richter S, Menger M. Microvascular consequences of Kuppfer cell modulation in rat liver fibrogenesis. J Pathol 1999; 189:85 - 91
   PubMed Web of Science ®Google Scholar
• Hudetz A. Percolation phenomenon: the effect of capillary network rarefaction. Microvasc Res 1993; 45:1 - 10
   PubMed Web of Science ®Google Scholar
• Greene A, Tonelato P, Lui J, Lombard J, Cowley A. Microvascular rarefaction and tissue vascular resistance in hypertension. Am J Physiol 1989; 256:126 - 131
   PubMed Web of Science ®Google Scholar
• Shih S-C, Ju M, Liu N, Smith L. Selective stimulation of VEGFR1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity. J Clin Invest 2003; 112:50 - 57
   PubMed Web of Science ®Google Scholar
• Carmeliet P. Angiogenesis in health and disease. Nat Med 2003; 9:653 - 660
   PubMed Web of Science ®Google Scholar
• O’Reilly M, Boehm T, Shing Y, Fukai N, Vasios G, Lane W, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88:277 - 285
   PubMed Web of Science ®Google Scholar
• Folkman J. Antiangiogenesis in cancer therapy—endostatin and its mechanism of action. Exp Cell Res 2006; 312:594 - 607
   PubMed Web of Science ®Google Scholar
• Im E, Venkatakrishnan A, Kazlauskas A. Cathepsin B regulates the intrinsic angiogenic threshold of endothelial cells. Mol Biol Cell 2005; 16:3488 - 3500
   PubMed Web of Science ®Google Scholar
• Rehn M, Veikkola T, Kukk-Valdre E, Nakamura H, Itmonen M, Lombardo C, et al. Interaction of endostatin with integrins implicated in angiogenesis. Proc Natl Acad Sci USA 2001; 98:1024 - 1029
   PubMed Web of Science ®Google Scholar
• Bates D, Cui T, Doughty J, Winkler M, Sugino M, Shields J, et al. VEGF165b, an inhibitory splice variant of VEGF, is downregulated in renal cell carcinoma. Cancer Res 2002; 62:4123 - 4131
   PubMed Web of Science ®Google Scholar
• Perrin R, Konopatskaya O, Qiu Y, Harper S, Bates D, Churchill A. Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of VEGF. Diabetologia 2005; 48:2422 - 2427
   PubMed Web of Science ®Google Scholar
• Noiri E, Peresleni T, Srivastava N, Weber P, Bahou W, Peunova N, Goligorsky MS. Nitric oxide is necessary for a switch from stationary to locomoting phenotype in epithelial cells. Am J Physiology 1996; 270:794 - 802
   PubMed Web of Science ®Google Scholar
• Noiri E, Hu Y, Bahou WF, Keese C, Giaever I, Goligorsky MS. Permissive role of nitric oxide in endothelin-induced migration of endothelial cells. J Biol Chem 1997; 272:1747 - 1752
   PubMed Web of Science ®Google Scholar
• Noiri E, Lee E, Testa J, Quigley J, Colflesh D, Keese C, et al. Podokinesis in endothelial cell migration: role of NO. Am J Physiol Cell 1998; 274:236 - 244
   PubMed Web of Science ®Google Scholar
• Yung Y, Chae J, Buehler M, Hunter C, Mooney D. Cyclic tensile strain triggers a sequence of autocrine and paracrine signaling to regulate angiogenic sprouting in human vascular cells. Proc Natl Acad Sci USA 2009; 106:15279 - 15284
   PubMed Web of Science ®Google Scholar
• Kilarski W, Samolov B, Petersson L, Kvanta A, Gerwins P. Biomechanical regulation of blood vessel growth during tissue vascularization. Nat Med 2009; 15:657 - 664
   PubMed Web of Science ®Google Scholar
• Ausprunk D, Falterman K, Folkman J. The sequence of events in the regression of corneal capillaries. Lab Invest 1978; 38:284 - 294
   PubMed Web of Science ®Google Scholar
• Ito M, Yoshioka M. Regression of the hyaloids vessels and papillary membrane of the mouse. Anat Embryol (Berl) 1999; 200:403 - 411
   PubMedGoogle Scholar
• Lobov I, Rao S, Carroll T, Vallance J, Ito M, Ondr J, et al. WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature. Nat 2005; 437:417 - 421
   Web of Science ®Google Scholar
• Jurasz P, Alonso D, Castro-Blanco S, Murad F, Radomski M. Generation and role of angiostatin in human platelets. Blood 2003; 102:3217 - 3223
   PubMed Web of Science ®Google Scholar
• VonTell D, Armulik A, Betscholtz C. Pericytes and vascular stability. Exp Cell Res 2006; 312:623 - 629
   PubMed Web of Science ®Google Scholar
• Yemisci M, Gursoy-Ozdemir Y, Vural A, Can A, Topalkara K, Dalkara T. Pericyte contraction induced by oxidative-nitrosative stress impairs capillary reflow despite successful opening of an occluded cerebral artery. Nat Med 2009; 15:1031 - 1038
   PubMed Web of Science ®Google Scholar
• Yamashita J, Itoh H, Hirashima M, Ogawa M, Nishikawa S, Yurugi T, et al. Flk-1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 2000; 408:92 - 96
   PubMed Web of Science ®Google Scholar
• DeRuiter M, Poelmann R, VanMunsteren J, Mironov V, Markwald R, Gittenberger-de Groot A. Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in vivo and in vitro. Circ Res 1997; 80:444 - 451
   PubMed Web of Science ®Google Scholar
• Frid M, Kale V, Stenmark K. Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation. Circ Res 2002; 90:1189 - 1196
   PubMed Web of Science ®Google Scholar
• Ishizaki A, Hayashi H, Li A, Imamura T. Human umbilical vein endothelium-derived cells retain potential to differentiate into smooth muscle-like cells. J Biol Chem 2003; 278:1303 - 1309
   PubMed Web of Science ®Google Scholar
• Hillebrands J, Klatter F, van den Hurk B, Popa E, Nieuwenhuis P, Rozing J. Origin of neointimal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis. J Clin Invest 2001; 107:1411 - 1422
   PubMed Web of Science ®Google Scholar
• Iwano M, Plieth D, Danoff T, Xue C, Okada H, Neilson E. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002; 110:341 - 350
   PubMed Web of Science ®Google Scholar
• Kalluri R, Neilson E. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003; 112:1776 - 1784
   PubMed Web of Science ®Google Scholar
• Thiery JP. Epithelial-mesenchymal transitions in development and pathologies. Curr Opinion Cell Biol 2003; 15:740 - 746
   PubMed Web of Science ®Google Scholar
• Liu J. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanisms and therapeutic intervention. J Am Soc Nephrol 2004; 15:1 - 12
   PubMed Web of Science ®Google Scholar
• O’Riordan E, Mendelev N, Patschan S, Patschan D, Eskander J, Cohen-Gould L, et al. Chronic NOS inhibition actuates endothelial-mesenchymal transformation. Am J Physiol Heart Circ Physiol 2007; 292:285 - 294
   Web of Science ®Google Scholar
• Stossel A, Paliege A, Thelig F, Addabbo F, Patschan D, Goligorsky MS, Bachmann S. Indolent course of tubulointerstitial disease in a mouse model of subpressor, low-dose nitric oxide synthase inhibition. Am J Physiol Renal 2008; 295:717 - 725
   Web of Science ®Google Scholar
• Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 2007; 13:952 - 961
   PubMed Web of Science ®Google Scholar
• da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all postnatal organs and tissues. J Cell Sci 2006; 119:2204 - 2213
   PubMed Web of Science ®Google Scholar
• Chen J, Park H-C, Pelger E, Li H, Plotkin M, Goligorsky MS. Mesenchymal stem cells participate in vasculogenesis, angiogenesis and endothelial repair. Kidney Interntl 2008; 74:879 - 889
   PubMed Web of Science ®Google Scholar
• Plotkin MD, Goligorsky MS. Mesenchymal cells from adult kidney support angiogenesis and differentiate into multiple interstitial cell types including erythropoietin-producing fibroblasts. Am J Physiol Renal Physiol 2006; 291:902 - 912
   Web of Science ®Google Scholar
• Mitchell R. Graft vascular disease: immune response meets vascular wall. Annu Rev Pathol Mech Dis 2009; 4:19 - 47
   PubMed Web of Science ®Google Scholar
• Davis S, Yeung A, Meredith I, Charbonneau F, Ganz P. Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year posttransplant. Circ 1996; 93:457 - 462
   PubMed Web of Science ®Google Scholar
• Iozzo RV. Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 1998; 67:609 - 652
   PubMed Web of Science ®Google Scholar
• Tran PK, Tran-Lundmark K, Soininen R, Tryggvason K, Thyberg J, Hedin U. Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-deficient perlecan. Circ Res 2004; 94:550 - 558
   PubMed Web of Science ®Google Scholar
• Pillarisetti S. Lipoprotein modulation of subendothelial heparan sulfate proteoglycans (perlecan) and atherogenicity. Trends Cardiovasc Med 2000; 10:60 - 65
   PubMed Web of Science ®Google Scholar
• Mongiat M, Sweeney SM, San Antonio JD, Fu J, Iozzo RV. Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan. J Biol Chem 2003; 278:4238 - 4249
   PubMed Web of Science ®Google Scholar
• Gonzalez EM, Reed CC, Bix G, Fu J, Zhang Y, Gopalakrishnan B, et al. BMP-1/Tolloid-like metalloproteases process endorepellin, the angiostatic C-terminal fragment of perlecan. J Biol Chem 2005; 280:7080 - 7087
   PubMed Web of Science ®Google Scholar
• Oda O, Shinzato T, Ohbayashi K, Takai I, Kunimatsu M, Maeda K, et al. Purification and characterization of perlecan fragment in urine of end-stage renal failure patients. Clin Chim Acta 1996; 255:119 - 132
   PubMed Web of Science ®Google Scholar
• Bix G, Fu J, Gonzalez EM, Macro L, Barker A, Campbell S, et al. Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through alpha2beta1 integrin. J Cell Biol 2004; 166:97 - 109
   PubMed Web of Science ®Google Scholar
• Bix G, Castello R, Burrows M, Zoeller J, Weech M, Iozzo R, et al. Endorepellin in vivo: targeting tumor vasculature and retarding cancer growth and metabolism. J Natl Cancer Inst 2006; 98:1634 - 1646
   PubMed Web of Science ®Google Scholar
• O’Riordan E, Orlova TN, Mendelev N, Patschan D, Kemp R, Chander PN, et al. Urinary proteomic analysis of chronic allograft nephropathy. Proteomics—Clinical Applications 2008; 2:1025 - 1035
   PubMed Web of Science ®Google Scholar
• Addabbo F, Ratliff B, Park H-C, Kuo MC, Sodhi K, Zhang F, et al. Mitochondrial function and mass are early victims of endothelial dysfunction. Am J Pathol 2009; 174:34 - 43
   PubMed Web of Science ®Google Scholar